The Food and Drug Administration warned that Intercept Pharmaceuticals Inc.'s (Nasdaq: ICPT) Ocalivia may cause liver damage and possible death. Shares of the biopharmaceutical collapsed $24.42 to close at $73.70.
Intercept Pharmaceuticals' Ocaliva may cause death
September 21, 2017 at 17:39 PM EDT